The Effect of Perioperative Uveitis Control on the Success of Glaucoma Surgery in Uveitic Glaucoma

References

• Neri P, Azuara-Blanco A, Forrester JV. Incidence of glaucoma in patients with uveitis. J Glaucoma. 2004;13(6):461–465. doi:10.1097/01.ijg.0000146391.77618.d0
   PubMed Web of Science ®Google Scholar
• Kalogeropoulos D, Sung VC. Pathogenesis of uveitic glaucoma. J Curr Glaucoma Pract. 2018;12(3):125–138. doi:10.5005/jp-journals-10028-1257
   PubMedGoogle Scholar
• Kalin-Hajdu E, Hammamji K, Gagné S, Harasymowycz P. Outcome of viscodilation and tensioning of Schlemm’s canal for uveitic glaucoma. Can J Ophthalmol. 2014;49(5):414–419. doi:10.1016/j.jcjo.2014.07.001
   PubMed Web of Science ®Google Scholar
• Jampel HD, Jabs DA, Quigley HA. Trabeculectomy with 5-fluorouracil for adult inflammatory glaucoma. Am J Ophthalmol. 1990;109(2):168–173. doi:10.1016/s0002-9394(14)75982-3
   Web of Science ®Google Scholar
• Towler HM, Bates AK, Broadway DC, Lightman S. Primary trabeculectomy with 5-fluorouracil for glaucoma secondary to uveitis. Ocul Immunol Inflamm. 1995;3(3):163–170. doi:10.3109/09273949509069109
   PubMedGoogle Scholar
• Patitsas CJ, Rockwood EJ, Meisler DM, Lowder CY. Glaucoma filtering surgery with postoperative 5-fluorouracil in patients with intraocular inflammatory disease. Ophthalmology. 1992;99(4):594–599. doi:10.1016/s0161-6420(92)31950-5
   Web of Science ®Google Scholar
• Hill RA, Nguyen QH, Baerveldt G, et al. Trabeculectomy and molteno implantation for glaucomas associated with uvettis. Ophthalmology. 1993;100(6):903–908. doi:10.1016/s0161-6420(93)31556-3
   Web of Science ®Google Scholar
• Gil–Carrasco F, Salinas–van Orman E, Recillas–Gispert C, et al. Ahmed valve implant for uncontrolled uveitic glaucoma. Ocul Immunol Inflamm. 1998;6:27–37. doi:10.1076/ocii.6.1.27.8078
   PubMed Web of Science ®Google Scholar
• Da Mata A, Burk SE, Netland PA, Baltatzis S, Christen W, Foster CS. Management of uveitic glaucoma with ahmed glaucoma valve implantation. Ophthalmology. 1999;106(11):2168–2172. doi:10.1016/S0161-6420(99)90500-6
   Web of Science ®Google Scholar
• Moorthy RS, Mermoud A, Baerveldt G, Minckler DS, Lee PP, Rao NA. Glaucoma associated with uveitis. Surv Ophthalmol. 1997;41(5):361–394. doi:10.1016/s0039-6257(97)00006-4
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509–516. doi:10.1016/j.ajo.2005.03.057
   PubMed Web of Science ®Google Scholar
• AlDarrab A, Malik R. Bilateral deep sclerectomy with microperforations as a successful secondary procedure in aniridia-associated glaucoma. Middle East Afr J Ophthalmol. 2018;25(1):52–55. doi:10.4103/meajo.MEAJO_291_17
   Web of Science ®Google Scholar
• Albahlal A, Alshamrani A, Khandekar R, Malik R. Outcome of surgical management of glaucoma following complex retinal detachment repair with silicone oil tamponade: drainage implant versus cyclophotocoagulation. J Glaucoma. 2020;29(3):198–204. doi:10.1097/IJG.0000000000001435
   Web of Science ®Google Scholar
• Forster DJ, Rao NA, Hill RA, Nguyen QH, Baerveldt G. Incidence and management of glaucoma in vogt-koyanagi-harada syndrome. Ophthalmology. 1993;100(5):613–618. doi:10.1016/s0161-6420(93)31604-0
   Web of Science ®Google Scholar
• Moorthy RS, Inomata H, Rao NA. Vogt-koyanagi-harada syndrome. Surv Ophthalmol. 1995;39(4):265–292. doi:10.1016/s0039-6257(05)80105-5
   PubMed Web of Science ®Google Scholar
• Giuliari GP, Chang PY, Thakuria P, Hinkle DM, Foster CS. Pars plana vitrectomy in the management of paediatric uveitis: the Massachusetts Eye Research and Surgery Institution experience. Eye. 2010;24(1):7–13. doi:10.1038/eye.2009.294
   PubMed Web of Science ®Google Scholar
• Quinones K, Choi JY, Yilmaz T, Kafkala C, Letko E, Foster CS. Pars plana vitrectomy versus immunomodulatory therapy for intermediate uveitis: a prospective, randomized pilot study. Ocul Immunol Inflamm. 2010;18(5):411–417. doi:10.3109/09273948.2010.501132
   PubMed Web of Science ®Google Scholar
• Ahn JK, Chung H, Yu HG. Vitrectomy for persistent panuveitis in behcet’s disease. Ocul Immunol Inflamm. 2005;13(6):447–453. doi:10.1080/09273940591004232
   PubMed Web of Science ®Google Scholar
• Zhang Z, Miao Y, Wang J, Zhou M, Fu M, Wang Y. Matricellular protein levels in aqueous humor and surgical outcomes of trabeculectomy. Invest Ophthalmol Vis Sci. 2018;59(10):3906–3910. doi:10.1167/iovs.18-24534
   PubMed Web of Science ®Google Scholar
• Ladas JG, Yu F, Loo R, et al. Relationship between aqueous humor protein level and outflow facility in patients with uveitis. Invest Ophthalmol Vis Sci. 2001;42(11):2584–2588.
   PubMed Web of Science ®Google Scholar
• Epstein DL, Hashimoto JM, Grant WM. Serum obstruction of aqueous outflow in enucleated eyes. Am J Ophthalmol. 1978;86(1):101–105. doi:10.1016/0002-9394(78)90023-5
   Web of Science ®Google Scholar
• Peretz WL, Tomasi T. Aqueous humor proteins in uveitis. Immunoelectrophoretic and gel diffusion studies on normal and pathological human aqueous humor. Arch Ophthalmol. 1961;65:20–23. doi:10.1001/archopht.1961.01840020022005
   PubMed Web of Science ®Google Scholar
• Norose K, Yano A, Wang XC, et al. Dominance of activated T cells and interleukin-6 in aqueous humor in vogt-koyanagi-harada disease. Invest Ophthalmol Vis Sci. 1994;35(1):33–39.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Struyf S, Descamps FJ, et al. Chemokines and gelatinases in the aqueous humor of patients with active uveitis. Am J Ophthalmol. 2004;138(3):401–411. doi:10.1016/j.ajo.2004.04.046
   Web of Science ®Google Scholar
• Abu El-Asrar AM, Struyf S, Kangave D, et al. Cytokine and CXC chemokine expression patterns in aqueous humor of patients with presumed tuberculous uveitis. Cytokine. 2012;59(2):377–381. doi:10.1016/j.cyto.2012.04.030
   PubMed Web of Science ®Google Scholar
• Ohira S, Inoue T, Iwao K, Takahashi E, Tanihara H, Acott TS. Factors influencing aqueous proinflammatory cytokines and growth factors in uveitic glaucoma. PLoS One. 2016;11(1):e0147080. doi:10.1371/journal.pone.0147080
   PubMed Web of Science ®Google Scholar
• Papadaki TG, Zacharopoulos IP, Pasquale LR, Christen WB, Netland PA, Foster CS. Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma. Am J Ophthalmol. 2007;144(1):62–69. doi:10.1016/j.ajo.2007.03.013
   Web of Science ®Google Scholar
• Bao N, Jiang ZX, Coh P, Tao LM. Long-term outcomes of uveitic glaucoma treated with ahmed valve implant in a series of Chinese patients. Int J Ophthalmol. 2018;11(4):629–634. doi:10.18240/ijo.2018.04.15
   Web of Science ®Google Scholar
• Sungur G, Yakin M, Eksioglu U, Satana B, Ornek F. Assessment of conditions affecting surgical success of ahmed glaucoma valve implants in glaucoma secondary to different uveitis etiologies in adults. Eye. 2017;31(10):1435–1442. doi:10.1038/eye.2017.84
   Web of Science ®Google Scholar
• McGhee CN. Pharmacokinetics of ophthalmic corticosteroids. Br J Ophthalmol. 1992;76(11):681–684. doi:10.1136/bjo.76.11.681
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M. Uveitis in behçet disease: an analysis of 880 patients. Am J Ophthalmol. 2004;138(3):373–380. doi:10.1016/j.ajo.2004.03.022
   PubMed Web of Science ®Google Scholar
• Rice JB, White AG, Scarpati LM, Wan G, Nelson WW. Long-term systemic corticosteroid exposure: a systematic literature review. Clin Ther. 2017;39(11):2216–2229. doi:10.1016/j.clinthera.2017.09.011
   PubMed Web of Science ®Google Scholar
• Richards RN. Side effects of short-term oral corticosteroids. J Cutan Med Surg. 2008;12(2):77–81. doi:10.2310/7750.2008.07029
   PubMed Web of Science ®Google Scholar
• Ladas JG, Wheeler NC, Morhun PJ, Rimmer SO, Holland GN. Laser flare-cell photometry: methodology and clinical applications. Surv Ophthalmol. 2005;50(1):27–47. doi:10.1016/j.survophthal.2004.10.004
   PubMed Web of Science ®Google Scholar
• Siddique SS, Suelves AM, Baheti U, Foster CS. Glaucoma and uveitis. Surv Ophthalmol. 2013;58(1):1–10. doi:10.1016/j.survophthal.2012.04.006
   PubMed Web of Science ®Google Scholar
• Schlote T, Derse M, Zierhut M. Transscleral diode laser cyclophotocoagulation for the treatment of refractory glaucoma secondary to inflammatory eye diseases. Br J Ophthalmol. 2000;84(9):999–1003. doi:10.1136/bjo.84.9.999
   Web of Science ®Google Scholar